Examiner: BUTTICE, AUDREY L

Tech Center 1600 • Art Units: 1644 1647 1658 1683

This examiner grants 47% of resolved cases

Performance Statistics

47.1%

Allow Rate

-12.9% vs TC avg

197

Total Applications

+26.0%

Interview Lift

1255

Avg Prosecution Days

Based on 140 resolved cases, 2023–2026

4.4%

§101 Eligibility

11.1%

§102 Novelty

39.6%

§103 Obviousness

30.7%

§112 Clarity

App #	Title	Status	Assignee
18417787	BRAIN TARGETING COMPOSITIONS AND METHODS OF USE THEREOF	Non-Final OA	Genentech, Inc.
18266848	CONDITIONALLY BISPECIFIC BINDING PROTEINS	Non-Final OA	Takeda Pharmaceutical Company Limited
18198404	METHODS OF TREATING CANCER USING LSD1 INHIBITORS IN COMBINATION WITH IMMUNOTHERAPY	Non-Final OA	President & Fellows of Harvard College

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.